Effects of functional level on balance in children with Duchenne Muscular Dystrophy

被引:22
作者
Alkan, Halil [1 ]
Mutlu, Akmer [1 ]
Firat, Tuzun [1 ]
Bulut, Numan [1 ]
Karaduman, Aynur Ayse [1 ]
Yilmaz, Oznur Tunca [1 ]
机构
[1] Hacettepe Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, TR-06100 Ankara, Turkey
关键词
Dynamic balance; Duchenne; Functional level; Muscular dystrophy; Static balance; GO TEST; DISEASE;
D O I
10.1016/j.ejpn.2017.02.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Introduction: This study was planned to compare the static and dynamic balance in children with Duchenne Muscular Dystrophy (DMD) at different functional levels with each other and with healthy peers. Material and methods: Sixty nine children between the ages of 6 and 11 were included in this study where 52 of them were diagnosed with DMD in Level I (18 patients), Level II (17 patients), and Level III (17 patients) according to Brooke Functional Classification Scale and 17 of them healthy peers were included. In order to assess static and dynamic balance pediatric functional reach test (PFRT) and timed up and go test (TUGT) were used. Results: When compared in terms of the TUGT, differences were found between all groups, i.e. Level 1 and 2, Level 2 and 3, Level 1 and 3, Healthy peers and Level 1, Healthy peers and Level 2, and Healthy peers and Level 3 (p < 0.0083). When compared in terms of the PFRT in the standing positions, there was difference between level 3 and healthy peers (p < 0.0083), but not between the other groups. Conclusions: We found poor functional level in DMD to affect the dynamic and static balance parameters in this study. The dynamic balance of a child with DMD at Level 3 is decreased to a third of a healthy peer. (C) 2017 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:635 / 638
页数:4
相关论文
共 16 条
[1]
Aras B, 2011, Sci Res Essays, V6, P4428
[2]
Bartlett Doreen, 2003, Pediatr Phys Ther, V15, P84, DOI 10.1097/01.PEP.0000067885.63909.5C
[3]
BHATTACHARYA A, 1995, DEV MED CHILD NEUROL, V37, P861
[4]
Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade [J].
Biggar, WD ;
Harris, VA ;
Eliasoph, L ;
Alman, B .
NEUROMUSCULAR DISORDERS, 2006, 16 (04) :249-255
[5]
CLINICAL-TRIAL IN DUCHENNE DYSTROPHY .1. THE DESIGN OF THE PROTOCOL [J].
BROOKE, MH ;
GRIGGS, RC ;
MENDELL, JR ;
FENICHEL, GM ;
SHUMATE, JB ;
PELLEGRINO, RJ .
MUSCLE & NERVE, 1981, 4 (03) :186-197
[6]
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management [J].
Bushby, Katharine ;
Finkel, Richard ;
Birnkrant, David J. ;
Case, Laura E. ;
Clemens, Paula R. ;
Cripe, Linda ;
Kaul, Ajay ;
Kinnett, Kathi ;
McDonald, Craig ;
Pandya, Shree ;
Poysky, James ;
Shapiro, Frederic ;
Tomezsko, Jean ;
Constantin, Carolyn .
LANCET NEUROLOGY, 2010, 9 (01) :77-93
[7]
Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids [J].
Goemans, Nathalie ;
van den Hauwe, Marleen ;
Wilson, Rosamund ;
van Impe, Annelies ;
Klingels, Katrijn ;
Buyse, Gunnar .
NEUROMUSCULAR DISORDERS, 2013, 23 (08) :618-623
[8]
BALANCE CONTROL IN PATIENTS WITH DISTAL VERSUS PROXIMAL MUSCLE WEAKNESS [J].
Horlings, C. G. C. ;
Kueng, U. M. ;
van Engelen, B. G. M. ;
Voermans, N. C. ;
Hengstman, G. J. D. ;
van der Kool, A. J. ;
Bloem, B. R. ;
Allum, J. H. J. .
NEUROSCIENCE, 2009, 164 (04) :1876-1886
[9]
Karaduman A, 2014, PEDIAT PHYS THERAPY
[10]
Effect of muscle weakness distribution on balance in neuromuscular disease [J].
Kaya, Pinar ;
Alemdaroglu, Ipek ;
Yilmaz, Oznur ;
Karaduman, Ayse ;
Topaloglu, Haluk .
PEDIATRICS INTERNATIONAL, 2015, 57 (01) :92-97